Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
LSL Pharma Group Inc ( (TSE:LSL) ) has provided an announcement.
LSL Pharma Group Inc. has announced a non-binding agreement to acquire a Quebec-based competitor specializing in liquid and semi-solid natural and cosmetic products. The acquisition is expected to add $8-10 million in revenue and enhance LSL Pharma’s capacity and service offerings. This strategic move is anticipated to generate significant synergies and strengthen the company’s market position by expanding its contract development and manufacturing operations. The transaction is expected to close by the end of the third quarter of 2025.
More about LSL Pharma Group Inc
LSL Pharma Group Inc. is a Canadian integrated pharmaceutical company that focuses on the development, manufacturing, and commercialization of high-quality sterile ophthalmic pharmaceutical products, as well as pharmaceutical, cosmetic, and natural health products in various dosage forms. The company includes subsidiaries such as Steri-Med Pharma Inc., LSL Laboratory Inc., Virage Santé Inc., and Dermolab Pharma Ltd.
Average Trading Volume: 49,266
Technical Sentiment Signal: Sell
For an in-depth examination of LSL stock, go to TipRanks’ Overview page.